PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 168 filers reported holding PTC THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $128,000 | +25.5% | 13,032 | -18.0% | 0.00% | +100.0% |
| Q1 2016 | $102,000 | -90.9% | 15,900 | -54.2% | 0.00% | -81.8% |
| Q4 2015 | $1,124,000 | +0.9% | 34,700 | -16.8% | 0.01% | 0.0% |
| Q3 2015 | $1,114,000 | -32.7% | 41,700 | +21.2% | 0.01% | -26.7% |
| Q2 2015 | $1,655,000 | +66.5% | 34,400 | +110.5% | 0.02% | +66.7% |
| Q1 2015 | $994,000 | – | 16,345 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |